Objective: Transmissible Pseudomonas aeruginosa (PA) strains have been described in CF and may be associated with a poorer prognosis. The "Prairie Epidemic Strain" (PES) has been recently identified in up to 30% of patients at prairie-based CF centres, however, its clinical impact remains to be determined. Methods: A cohort study of adults with cystic fibrosis from 1981-2014 was conducted and all PA isolates from clinical visits were prospectively collected. PA strain typing at clinic enrolment, and most recent was conducted by PFGE. Patients were divided into one of four cohorts: no PA, transient PA, unique chronic PA, and chronic PES. Random effects and proportional Cox hazard models were conducted for outcome of death, transplantation and FEV1% decline. Results: 204 patients (54% male) with CF were analysed: 38 no PA, 20 transient PA, 103 unique PA, 43 PES. Baseline FEV1% was lowest in the chronic PES group (p = 0.002). Overall rate of FEV1% decline was −1.19%/year (95% CI: −1.41 to −0.97, p < 0.001); the chronic PES group had the greatest rate of decline at −1.24%/year (p < 0.001). There were a total of 42 deaths and 37 transplants through 1862 and 2050 follow-up years, respectively. The age-adjusted hazard ratio (HR) for death was not different for the PA groups compared to the no PA group. Relative to the no PA group, risk of transplant was increased in those with chronic PES (HR 9.13, CI 1.29−69, p = 0.032) compared to the no PA group. Conclusion: Chronic PES infection is significantly associated with a greater rate of FEV1% decline and risk of lung transplantation but not with increased risk of death compared to no PA infection.
Burkholderia cepacia complex (Bcc) is recognized as a significant respiratory pathogen in Cystic Fibrosis (CF) patients. The identification at species level among the 18 established Bcc members is an essential tool for epidemiological studies and infection control policies. In the early 2000s the epidemiology of Burkholderia cepacia (Bcc) in Argentina was characterized by the occurrence of a B. contaminans outbreak that took place in major CF centres. This situation was quite different from other countries where B. cenocepacia and B. multivorans have been the most frequent Bcc infecting species in CF patients. Although B. contaminans outbreak was studied, little is known about the evolution of Bcc epidemiology during the last years. The aim of this study was to analyse Bcc infections in CF patients (pt) attending Hospital de Niños "R. Gutiérrez" in 3 different periods between 2004 and 2014. Incidence and distribution of Bcc species have been described. 2004-2005: Incidence 13.5% (22/163 pt). B. contaminans 55.6% (10/18), B. cepacia 16.7% (3/18), B. cenocepacia and B. seminalis 11.1% (2/18) , B. multivorans 5.6% (1/18), 4 nonviable strains. 2007-2009: Incidence 6.6% (12/181 pt). B. contaminans 72.7% (8/11), B. cepacia 27.3% (3/11), 1 nonviable strain. 2012-2014: Incidence 5.4% (10/184 pt). B. contaminans 90% (9/10), B. cepacia 10% (1/10). Conclusions: B. contaminans remains the most frequent isolated species among the new cases of infection. Although incidence values have decreased, these results suggest the situation with B. contaminans hasn't been solved yet. More studies specially focusing on the transmission of these bacteria and the possible sources of infection are needed.
